February 2024
1. CHECK JH, Check DL, DO TP, Srivastava M, et al
   Significant Palliative Benefits Following Therapy With Mifepristone for Advanced Treatment Resistant Small Cell Lung Cancer.
   Anticancer Res. 2024;44:659-664.
   

   >> Share

   
   August 2023
2. KOROSUE M, Nakagawa K, Yoshiyasu K, Narita S, et al
   Medroxyprogesterone as the Initial Systemic Treatment of Recurrent Endometrial Cancer: A Single Institutional Study.
   Anticancer Res. 2023;43:3693-3699.
   

   >> Share

   
   June 2023
3. KANGA KJW, Kanga LHB, Mendonca P, Soliman KFA, et al
   Attenuative Effect of Diallyl Trisulfide on Caspase Activity in TNF-alpha-induced Triple Negative Breast Cancer Cells.
   Anticancer Res. 2023;43:2393-2405.
   

   >> Share

   
   February 2022
4. SHIMADA T, Izumi K, Kano H, Kadomoto S, et al
   Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer.
   Anticancer Res. 2022;42:1065-1071.
   

   >> Share

   
   December 2021
5. KANGA KJW, Mendonca P, Soliman KFA, Ferguson DT, et al
   Effect of Diallyl Trisulfide on TNF-alpha-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells.
   Anticancer Res. 2021;41:5919-5933.
   

   >> Share

   
   
6. CHECK JH, Check D
   New Insights as to Why Progesterone Receptor Modulators, such as Mifepristone, Seem to Be More Effective in Treating Cancers that Are Devoid of the Classical Nuclear Progesterone Receptor.
   Anticancer Res. 2021;41:5873-5880.
   

   >> Share

   
   April 2021
7. CHECK JH, Check D, Poretta T, Wilson C, et al
   Palliative Benefits of Oral Mifepristone for the Treatment of Metastatic Fibroblastic Osteosarcoma.
   Anticancer Res. 2021;41:2111-2115.
   

   >> Share

   
   December 2020
8. CHECK JH, Check D, Srivastava MD, Poretta T, et al
   Treatment With Mifepristone Allows a Patient With End-stage Pancreatic Cancer in Hospice on a Morphine Drip to Restore a Decent Quality of Life.
   Anticancer Res. 2020;40:6997-7001.
   

   >> Share

   
   November 2020
9. GADDUCCI A, Cosio S, Fruzzetti F
   Estro-progestin Contraceptives and Risk of Cervical Cancer: A Debated Issue.
   Anticancer Res. 2020;40:5995-6002.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share